Dendritic cells (DCs) that orchestrate mucosal immunity have been studied in mice. Here we characterized human gut DC populations and defined their relationship to previously studied human and mouse DCs. CD103 + Sirpa − DCs were related to human blood CD141 + DCs and to mouse intestinal CD103 + CD11b − DCs and expressed markers of cross-presenting DCs. CD103 + Sirpa + DCs aligned with human blood CD1c + DCs and mouse intestinal CD103 + CD11b + DCs and supported the induction of regulatory T cells. Both CD103 + DC subsets induced the T H 17 subset of helper T cells, while CD103 − Sirpa + DCs induced the T H 1 subset of helper T cells. Comparative analysis of transcriptomes revealed conserved transcriptional programs among CD103 + DC subsets and identified a selective role for the transcriptional repressors Bcl-6 and Blimp-1 in the specification of CD103 + CD11b − DCs and intestinal CD103 + CD11b + DCs, respectively. Our results highlight evolutionarily conserved and divergent programming of intestinal DCs.
r e s o u r c e
The gastrointestinal tract is challenged by a multitude of agents, including commensal microflora, food antigens and invasive pathogens. Animal models have begun to define a critical role for dendritic cell (DC) specialization in achieving balance between tolerogenic immune responses and inflammatory immune responses in the intestine. Diversity in intestinal DC phenotype and function has been studied extensively in mice through the use of model systems based on conditional ablation of DCs and engraftment with defined precursors of DCs 1,2 . Mouse CD103 + CD11b + DCs (called 'mouse double-positive (mDP) DCs' here) and CD103 + CD11b − DCs (called 'mouse singlepositive (mSP) DCs' here) require distinct genetic factors for their development and display unique gene-expression profiles 3 . The mSP DCs are closely related to cross-presenting CD8α + DCs of splenic origin, and both require the transcription factors BATF3, Id2 and IRF8 for development 4 . The mDP DCs are potent inducers of CD4 + T cell responses of both inflammatory natures and tolerizing natures [5] [6] [7] [8] and share with lymph tissue-resident CD4 + CD8α − DCs a requirement for the transcription factors IRF4 (ref. 9 ) and Notch2 (ref. 10) .
Published studies have identified CD141 as a marker of human crosspresenting conventional DCs (cDCs), the putative homologs of mouse CD8α + DCs, in human blood, spleen, lymph nodes and skin [11] [12] [13] . In addition, CLEC9A + Sirpα − CD103 + DCs have been identified in the human ileum 9 . However, the phenotypic features and functional specialization of human intestinal DCs, as well as the transcriptional programs of various DC subsets, remain to be studied.
Our goal here was to identify discrete DC subsets in the human intestinal lamina propria (LP), to relate them to mouse intestinal DC populations by identifying evolutionarily conserved phenotypic features and to start characterizing their functional specialization. We also used genome-wide expression analysis to define transcriptional fingerprints for each DC subset in the gut and to correlate gene expression in human and mouse DC subsets from lymphoid and nonlymphoid sites. We identified CD103 (integrin α E ) and Sirpα (CD172a; a receptor for the signal-regulatory protein CD47) as conserved markers that defined three major subpopulations of conventional CD11c + DCs in the human gut mucosa. Our analyses revealed that human CD103 + Sirpα + DCs (called 'human double-positive (hDP) DCs' here) and mDP DCs shared a common set of phenotypic characteristics (i.e., CLEC4A + CD101 + TLR5 + CCR7 hi CD11b + Sirpα + ). Human gut CD103 + Sirpα − DCs (called 'human single positive (hSP) DCs' here) showed substantial similarities in phenotype and transcriptome with CD141 + DCs from human blood and mSP DCs, including shared expression of CLEC9A, CADM1 and XCR1 (ref. 13) . We also identified a population of human CD103 − Sirpα + cDCs that had increased frequency in inflamed gut specimens and expressed transcription factors and gene profiles consistent with monocyte-derived DCs.
Through the use of comparative analysis of transcriptomes, we identified transcription factors whose expression was coordinately regulated in those human and mouse intestinal DC subsets. In addition to IRF8, a transcription factor linked to intestinal DC development, our analyses revealed conserved expression of Bcl6 in hSP and mSP DCs and of Irf4 and Prdm1 (which encodes Blimp-1) in hDP and mDP DCs. Selective loss of intestinal mDP DCs has been reported in mice with DC-specific IRF4 deficiency 9, 14 . We report here that Bcl-6 and Blimp-1 controlled the specification of intestinal mSP and mDP DC subsets. Bcl-6 was required for the development of intestinal mSP DCs, as well as for that of lymphoid tissue CD8α + DCs, while Blimp-1 deficiency specifically affected the unique mDP subset in the intestine. Hence, in parallel to their counter-regulatory roles in the differentiation of effector T cells and B cells, Bcl-6 and Blimp-1 served opposing roles in the specification of mSP DCs and mDP DCs in the intestinal LP.
RESULTS

Sirpa and CD103 define cDC subsets in the human small intestine
To characterize DC subsets in the human small intestine (SI), we prepared cell suspensions from the LP of the jejunum of patients undergoing bariatric surgery. We defined cDCs as lineage-negative (Lin − : CD3 − CD19 − CD14 − CD56 − ) CD45 + MHCII + CD11c + CD123 − cells. We established CD103 and Sirpα as suitable markers with which to characterize CD11c + cDC subsets in LP cell preparations. CD103, an integrin linked to the interaction of DCs with epithelial E-cadherin, defines a major migratory intestinal cDC population in the mouse 15 and distinguishes that population from CD103 − CD11b + monocyte-derived LP macrophages. Sirpα (CD172a), a receptor for CD47, defined discrete subsets of CD103 + cDCs and CD103 − cDCs (Fig. 1a) . CD11b, used to categorize mouse gut CD103 + DCs into subsets, was coexpressed with Sirpα ( Fig. 1b) , but its staining was consistently weak. CD103 and Sirpα together defined four populations of CD11c + cDCs in the SI LP ( Fig. 1a ; full gating strategy, Supplementary Fig. 1 ). Because CD103 − Sirpα − DCs were a minor population among LP CD11c + cDCs, which limited our ability to characterize them, we will not discuss them further here.
All the DC subsets had similar expression of HLA-DR, as assessed by flow cytometry, but they varied in their expression of other maturation molecules (such as CD83) and costimulatory molecules (CD86, CD40 and CD80; Fig. 1b ). CD103 + Sirpα + (hDP) DCs had high expression of CD86 and CD83, while CD103 − Sirpα + DCs had intermediate expression of CD86 and CD83 and CD103 + Sirpα − (hSP) DCs had low expression of CD86 ( Fig. 1b) . Both hDP and hSP DCs had high expression of the costimulatory receptor CD40; in contrast to blood DC subsets 16 , all gut DC subsets expressed CD40, albeit at varying levels ( Fig. 1b) . However, both gut and blood DCs had similar expression of CD86 and CD80 (refs. 12,16) ( Fig. 1b) . None of the gut DC subsets expressed CD64 (Fig. 1b) , a characteristic macrophage marker in both humans and mice 17 (Supplementary Fig. 2a ).
To determine whether the DC subsets occupy discrete microenvironments, we analyzed frozen sections of jejunal tissue by immunofluorescence studies. All the DC subsets defined by expression of CD103 and Sirpα were present in the LP, with intermingling of CD103 + Sirpα − (hSP) cells, CD103 + Sirpα + (hDP) cells and CD103 − Sirpα + CD11c + cells in the LP villus core ( Fig. 1c ). Histology and cell-suspension analysis showed that hDP DCs were the dominant subset in the jejunal LP of most patients ( Fig. 1c,d) . In two patients whose jejunal tissue had a hyperemic phenotype indicative of inflammation, CD103 − Sirpα + DCs were substantially greater in frequency and constituted the majority of CD11c + DCs (Fig. 1d) . The relative representation of DC subsets was different in the colonic LP, where CD103 − Sirpα + and hSP DCs predominated (Supplementary Fig. 3) . The increased frequency of hDP DCs in the proximal intestine parallelled a greater representation of mDP DCs in the mouse SI than in the mouse large intestine 18 . Together these data showed that the human LP contained three major DC populations that included CD103 + Sirpα + (hDP) DCs, CD103 + Sirpα − (hSP) DCs and CD103 − Sirpα + DCs.
Different expression of chemokine receptors and integrins
Similar to DCs in human blood 19 (P.B.W., data not shown), all cDC subsets in the LP exhibited high expression of the mucosa-associated integrin α 4 β 7 (Fig. 2a) r e s o u r c e npg r e s o u r c e as profiled before 12 . Hierarchical clustering suggested a close relationship between gut hSP DCs and cross-presenting blood CD141 + DCs, whereas hDP DCs clustered with the major blood CD1c + DC subset. CD103 − Sirpα + DCs clustered with blood monocytes (Fig. 3a) , consistent with the possibility that they are derived from recruited monocytes. Although the clusters highlighted above ( Fig. 3a) had statistically significant differences in transcriptional profiles, the clustering of hDP DCs with CD1c + DCs was not robust with respect to gene-set selection criteria or clustering algorithm. We therefore assessed the pairwise correlation of gene expression in individual hDP DC samples with those of blood and skin DC and monocytes. Three of the hDP DC samples showed significant correlation with blood CD1c + DCs, while the other two aligned with skin CD1c + DCs (P < 0.001; Supplementary Fig. 4a ), which may have reflected differences in tissue-variant gene expression. Consistent with the clustering results, hSP DCs and CD103 − Sirpα + DCs correlated best with CD141 + blood DCs and with monocytes, respectively ( Supplementary Fig. 4a ). CD103 − Sirpα + intestinal DCs also aligned weakly but significantly with CD14 + skin DCs (P = 0.01; Supplementary Fig. 4a ), a population related to monocytes as well 12 .
To assess the relationship of gut DCs with blood DCs and monocytes independently of tissue-specific genes, we took advantage of DC lineage-associated gene sets developed before 12 , from which skin and blood-specific genes were specifically excluded. We additionally excluded gut-specific genes (genes with a significant difference in expression in pooled gut, skin and blood samples) and selected genes whose expression differed significantly between gut DC subsets (full gene list for Fig. 3b, Supplementary Table 1 ). Through the use of Pearson's correlation, we found that the set of genes in hDP DCs showed significant enrichment for genes associated with CD1c + lineage DCs, as evident from alignment of hDP DCs with blood CD1c + DCs (Fig. 3b) . Similarly, hSP aligned with blood CD141 + DCs in their expression of genes associated with DCs of the CD141 + DC lineage, and CD103 − Sirpα + DCs aligned with blood monocytes in their expression of genes of the monocyte lineage ( Fig. 3b) . of the chemokine receptor CCR9 is restricted to pDCs under homeostatic conditions 20 , in the human SI, CCR9 was expressed by a subset of hDP DCs ( Fig. 2a) and was not detectable on pDCs (data not shown). In the mouse LP, CD11c + F4/80 hi CD11b + CD103 − macrophages have high expression of the chemokine receptor CX3CR1, whereas CD11c + CD11b + CD103 − DCs have lower CX3CR1 expression 21 . In contrast to human gut CD14 + macrophages, which had high expression of CX3CR1 ( Supplementary Fig. 2b ), CD103 − Sirpα + DCs had intermediate expression of CX3CR1, and the marker was absent on the other DC subsets ( Fig. 2a) .
In the mouse, the chemokine receptor CCR6 controls the localization of CD11c + CD11b + DEC205 − DCs in Peyer's patches 22 . In human LP, there was high expression of CCR6 on both subsets of intestinal LP CD103 + DCs ( Fig. 2a) , while CXCR3 was selectively expressed on hSP DCs ( Fig. 2a ). Because intestinal DCs use the chemo kine receptor CCR7 to access lymphatic vessels 23 , we assessed the expression of CCR7 on human LP DC subsets. Similar to migratory mDP DCs, hDP DCs had high expression of CCR7 ( Fig. 2a) , which suggested that they may migrate via lymphatics to the mesenteric lymph nodes (MLNs) in vivo. In support of that idea, hDP DCs were present in the MLNs, where they also displayed high expression of CCR7 ( Fig. 2b) . Furthermore, immunohistology revealed abundant hDP DCs in the gut-draining MLNs but a complete absence of those DCs in the appendix, which lacks afferent lymphatics ( Fig. 2c,d) . The CD103 − Sirpα + and hSP subsets also expressed CCR7 ( Fig. 2a) , which suggested that they may also be able to enter lymphatics and migrate to the MLNs. These results defined conserved and divergent subset expression of chemoattractant and trafficking programs in humans versus mice. Notably, patterns of CX3CR1 expression were conserved in DCs and macrophages in the gut, and CCR7 expression seemed to define migratory subsets.
Gene-expression and surface-receptor profiling of human gut DCs
Next we sorted hDP, hSP and CD103 − Sirpα + subsets from human gut and did genome-wide transcriptional profiling. We used genes with variable expression to align the three human gut DC subsets with human blood and skin DCs and blood monocyte populations npg r e s o u r c e Blood CD141 + DCs efficiently cross-present antigen and share phenotypic and functional properties with mouse cross-presenting CD8α + lymphoid DCs 12 . A scatterplot of normalized gene expression revealed a strong correlation in the gene expression of gut hSP DCs and that of blood CD141 + DCs (Fig. 3c) . The two populations shared expression of the gene encoding CD141, as well as of core crosspresenting DC signature genes, including those encoding the chemokine receptor XCR1, which supports the migration of DCs to the chemokine XCL1 expressed by CD8 + T cells ( Fig. 3c) ; the lectin receptor CLEC9A, which mediates the uptake of apoptotic cells ( Fig. 3c, npg r e s o u r c e the adhesion receptor CADM1, which may promote the induction of cytotoxic T lymphocyte responses 24 (Fig. 3c) . Notably, hSP DCs had higher expression of IDO1, CLEC1A and BTLA, which encode molecules associated with dampening of the immune response ( Fig. 3c,f) , and NLRC5, which encodes a key regulator of the major histocompatibility complex class I that is involved in immune responses to intracellular pathogens 25 (Fig. 3c,f) . Flow cytometry confirmed that hSP DCs had high expression of CD141 and CLEC9A ( Fig. 3e ) but lacked expression of the markers CLEC4A (DCIR), CD101, CD206 ( Fig. 3e) and CD11b ( Fig. 1b) . Collectively, these results indicated a close relationship between intestinal hSP DCs and CD141 + crosspresenting DCs in blood and other tissues. hDP DCs expressed many receptors, such as CD101 (ref. 26 ), CLEC4A, CD206 (mannose receptor) and CD209 (DC-SIGN), that have been described as markers of mDP DCs ( Fig. 3c,e ; comparative analysis of transcriptomes below). They displayed high expression of the lectin immunoregulatory receptors CLEC4A ( Fig. 3e ) and CLEC10A (data not shown) and of the immunoglobulin superfamily member CD101 ( Fig. 3e) . CD103 − Sirpα + DCs had intermediate expression of CD101 and CLEC4A ( Fig. 3e) , whereas (as noted above) hSP DCs did not express these markers. Toll-like receptor 5 (TLR5) was expressed by the two Sirpα + DC subsets but not by hSP DCs (Fig. 3e) . Expression of the endocytic receptors CD206, CD209 and CD207 (langerin) was restricted to hDP DCs (Fig. 3e) . IRF4 also had high expression in hDP DCs but no expression in hSP DCs (Fig. 3e) . Thus, hDP gut DCs shared many phenotypic features with their intestinal mDP DC counterparts.
Several genes associated with tolerance induction were 'preferentially' expressed by hDP DCs, such as VSIG4, which encodes a member of the B7 (coreceptor CD28 ligand) superfamily and negative regulator of T cell activation ( Fig. 3d) ; IRAK3, which encodes a key inhibitor of the kinase IRAK-transcription factor NF-κB pathway in chronic inflammation; TGFBR2, which encodes a receptor involved in signaling via transforming growth factor-β; and PILRA, which encodes an inhibitory receptor that also serves as an entry receptor for herpes simplex virus (data not shown). hDP DCs also specifically expressed transcripts encoding molecules involved in regulating IL-22 (ref. 27 ), a cytokine that can promote pathological inflammatory responses in the intestine 28 . Those included transcripts that encode the cytosolic sensor NLRP3, the apoptosis-related enzyme caspase-1, the cytokine IL-18 and the soluble IL-22 cytokine receptor IL-22RA2 ( Fig. 3f) .
We assessed the genes coregulated in gut hDP DCs and blood CD1c + subsets by comparing gene expression in each of those with that of CD141 + DCs derived from the same tissue. Plotting the change in gene expression in CD1c + DCs versus CD141 + DCs in blood relative to that in hDP DCs versus CD141 + hSP DCs in the gut revealed that most genes with variable expression were coordinately regulated in the gut and blood DC subsets ( Fig. 3d) . Most of those genes were also coordinately regulated in skin CD1c + DCs and CD141 + DCs. However, several genes expressed by gut hDP DCs and blood CD1c + DCs, including CLEC10A, CLEC4A, ALOX5 and GIMAP4, were downregulated in skin CD1c + DCs. Genes 'preferentially' expressed by CD1c + DCs in all sites (i.e., by blood CD1c + DCs versus blood CD141 + DCs, by skin CD1c + DCs versus skin CD141 + DCs, and by gut hDP DCs versus gut hSP DCs) included CD1C, CD1E, SIRPA, IGSF6, IRF4 and MS4A6A.
Gene expression by gut CD103 − Sirpα + DCs showed significant correlation with that of blood monocytes (Supplementary Fig. 4) , especially CD14 + monocytes. Notably, CD103 − Sirpα + DCs fulfilled the criteria now used to distinguish DCs from macrophages. First, they expressed CD11c but lacked expression of the canonical macrophage antigens CD14 and CD64 (Fig. 1b) . Second, intestinal CD103 − Sirpα + DCs were as efficient as hDP DCs, and better than hSP DCs, at promoting the population expansion of T cells in allogenic coculture, a feature that distinguishes DCs from macrophages ( Supplementary  Fig. 5a ). Finally, the ratio of the expression of the transcription factor PU.1 to that of the transcription factor Mafb, which determines whether a myeloid precursor acquires a macrophage fate or a DC fate 29 , was similar in CD103 − Sirpα + DCs and other gut DC subsets and was much lower in all three gut DC subsets than that in macrophages ( Supplementary Fig. 5b ).
Together these results established a close relationship between intestinal hSP DCs and CD141 + cross-presenting DCs in blood and r e s o u r c e other tissues, as well as between gut hDP DCs and the blood CD1c + DC lineage. They suggested that gut CD103 − Sirpα + DCs represented a true DC population, probably derived from monocytes recruited in response to inflammation. That hypothesis was consistent with the high frequency of CD103 − Sirpα + DCs in the LP isolates of two specimens with hyperemic intestinal mucosa (Fig. 1d) .
The 'education' of CD4 + T cells by human intestinal DCs
Intestinal DCs moderate gut immune responses in part by inducing CD4 + regulatory T cells (T reg cells) 18 . In humans, T reg cells are phenotypically identifiable as Foxp3 + CD127 lo CD25 hi CD4 + T cells 30 . We primed human allogeneic naive peripheral blood CD4 + T cells with DC subsets sorted from the LP and assessed expression of the transcription factor Foxp3 and the cytokine receptors CD25 (IL-2Rα) and CD127 (IL-7Rα) on responding CD4 + T cells after 9 d. hDP DCs and CD103 − Sirpα + DCs both supported robust T cell proliferation. hDP DCs were the most efficient inducers of Foxp3 + CD127 lo cells (Fig. 4a,b) . In contrast, hSP DCs induced less T cell proliferation ( Supplementary Fig. 5a ), and fewer T cells responding to hSP DCs or to CD103 − Sirpα + DCs upregulated Foxp3 expression ( Fig. 4a) .
The induction of T reg cells by mouse gut DCs is mediated in part by the activity of retinaldehyde dehydrogenase (RALDH) in DCs, which produces retinoic acid for presentation to responding T cells 7 . To assess whether the differences in induction of Foxp3 + CD127 lo CD4 + T cells correlated with RALDH activity, we incubated human DC subsets with a fluorogenic substrate used to identify human cells with high expression of RALDH, in the presence or absence of the RALDH inhibitor DEAB, then assessed fluorescence by flow cytometry. The hDP DCs as well as CD103 − Sirpα + DCs displayed higher RALDH activity than that of hSP DCs (Fig. 4c) . Similarly, mDP DCs display higher RALDH activity and greater efficiency in inducing Foxp3 + CD4 + T reg cells than do mSP DCs 18 . In the context of intestinal immune responses, DC-driven production of retinoic acid also 'imprints' the responding T cells with trafficking receptors for homing to the SI 31 . Consistent with the pattern of RALDH activity in the DC subsets, hDP DCs were strong inducers of CCR9 expression on CD4 + T cells, but all subsets of gut DCs were able to induce CCR9 expression ( Fig. 4d) . In humans and mice, the gut microbiota and their metabolites act via resident DCs in the steady state to promote IL-17 production in T cells in the SI LP 32, 33 . We assessed the capacity CLEC9A  LEPREL1  GCET2  TLR3  KIAA1598  CLNK  CLEC1A  TSPAN33  BTLA  ADAM19  TAP2  ZNF366  PPAP2A  CADM1  RASGRP3  DNASE1L3  DPP4  LY75  MAP2K6  CCR9  SLAMF7  FMNL2  NET1  CXCL9  CPNE3  ASB2  SLC46A3  GPR31  FLT3  ANPEP  RAB30  VCAM1  SERPINB9  ENPP1  IRF8  C1orf54  SMAD3  SELL  AHNAK  HLA-DOA  CDH17  ARAP2  KYNU  CD4  SPINT1  TFRC  P2RY10  CASP1  LAIR1  CLEC4A  ABCB1  MMP12  MS4A6A  PRDM1  RNF130  CLEC10A  CD101  IRF4  SIRPA  FCERG1  IFITM2  TMEM71  CYBB  CD300A  ZEB2  IGSF6  ITGAM  CSF1R  CAPG  GLUL  PLA2G7  ALOX5AP  IFITM3  GAPT  HPGD  SIRPB1  LAMP1  MPP1  PYGL  FCGR2A  THBS1  EMR1  TLR4  C3AR1  DUSP6  IRAK3  CX3CR1  ALOX5  LRP1  EMILIN2  VWA5A  F13A1  C3  PLAUR  CD300LB CTSD FCGR2B FCGR1A npg r e s o u r c e of human gut DC subsets sorted from the LP to stimulate and polarize naive CD4 + T cells in an allogeneic mixed-leukocyte reaction. After 9 d of coculture, we restimulated the responding allogeneic CD4 + T cells with the phorbol ester PMA and ionomycin and stained intracellular cytokines. LP hDP and hSP DCs induced the highest frequency of IL-17-producing helper T cells, whereas CD103 − Sirpα + DCs were relatively inefficient ( Fig. 4e) . That result was consistent with the ability of mDP DCs from the SI to skew T cells toward the T H 17 subset of helper T cells 9, 14, 18 . In contrast, the CD103 − Sirpα + DC subset was most efficient at skewing responding CD4 + T cells toward interferon-γ production ( Fig. 4f) , similar to monocyte-derived mouse intestinal inflammatory DCs (CD103 − CX3CR1 int DCs), which are also efficient inducers of the T H 1 subset of helper T cells 34 . Differences in CD4 + T cell priming could reflect differences in the steady-state expression of cytokines by the DCs. However, genes encoding key cytokines involved in T cell differentiation (IL-6, IL-23, IL-12 and IL-10) had low expression, if any (Affymetrix mean raw expression value <150), in all DC subsets at steady state. Future studies should analyze cytokine expression by activated DC subsets in vitro and by DCs in inflamed settings.
Comparison of mouse and human DC subsets
We next sought to compare the gene-expression profiles of human and mouse gut DC subsets to further assess their relationships and to define evolutionarily conserved DC subset signatures. We identified sets of human genes or their mouse homologs with different expression by the three human gut DC subsets profiled here; by mouse gut mSP DCs, mDP DCs and CD11b + macrophages; and by mouse spleen CD4 + or CD8α + DCs and red pulp macrophages (data from the Immunological Genome Project). We used normalized expression (robust multiarray average method) of genes common to the three gene sets noted above to cluster human and mouse DCs and monocytemacrophage cell types ( Fig. 5a ; full gene list for Fig. 5a, Supplementary  Table 2 ). Hierarchical clustering by a Euclidean distance metric indicated significant similarity among hSP DCs, intestinal mSP and cross-presenting splenic CD8α + DCs (called 'cluster 1' here). Intestinal hDP DCs clustered with mDP and spleen CD4 + DCs (called 'cluster 2' here; Fig. 5a ). Human intestinal CD103 − Sirpα + DCs clustered with mouse blood Ly6c + monocytes (Fig. 5a) , which supported the proposal of their relationship with human blood monocytes (Fig. 3a) . Mouse gut CD11b + macrophages and spleen red pulp macrophages, both thought to represent resident macrophages, formed a separate cluster (Fig. 5a) . Data on the transcriptome of mouse inflammatory CD103 − CD11b + CX3CR1 int DCs from the LP were not available and thus we did not compare their gene-expression profile with that of human CD103 − Sirpα + CX3CR1 int DCs.
We identified genes whose expression differed at least fourfold between the clusters for heatmap visualization (Fig. 5b) . Genes in cluster 1 showed enrichment for transcripts encoding molecules of a wide range of functional groups, including solute carriers, inhibitory and activating ligands, adhesion and signaling molecules. In particular, XCR1, CLEC9A, TLR3 and CADM1 appeared as highly conserved markers of cluster 1 (hSP, mSP, CD8α + cross-presentinglike) DCs in mouse and human (Fig. 5b) . The transcription factors Cells (normalized to mode) EHF  MYCL1  TCF19  ZNF367  KLF2   IRF8  Bcl6   SMAD3  RUNX1  MYC   FOSL2  STAT4  TSHZ1  LASS6  REL  NR4A3  ETV3  ZFP36L2   HES1  BHLHE40  PPARG  CSRNP1  BACH1  PBX1  ZNF496  PTGER3   FOXO3B  ETS2  ZHX2  SATB1  MEF2C  MTA3   NR1D2  CEBPB  HIF1A  CREB3L2  AHR  ZNF238   IRF4  PRDM1  ZEB2  HIVEP2  FOXN3   GTF2IRD1  TRPS1  ZSCAN20  IRF7 (Figs. 5b and 3c) , which suggested conservation of genes encoding molecules that control the differentiation of cells in cluster 1. Genes 'preferentially' expressed by DCs of cluster 2 included those encoding the canonical CD4 + DC marker CLEC4A, CD101 and IRF4, which is linked to the development of CD4 + DCs and mDP DCs in the mouse (Fig. 5b) . DCs of cluster 2 also shared expression of ABCB1 (an ATP-dependent xenobiotic efflux transporter, variants of which are associated with inflammatory bowel disease), and the list of genes 'preferentially' expressed by this group showed enrichment for genes encoding molecules that enhance leukocyte motility, including the Rac GTPaseactivating proteins Vav2 and Dock4. Human and mouse monocytes and CD103 − Sirpα + DCs also shared expression of many genes, such as those encoding the interferon-induced antiviral protein IFITM2 and the C5A receptor, which distinguished them from DCs derived from committed precursors of DCs.
Intestinal hDP DCs, although included in cluster 2, shared expression of many genes with cells of cluster 3 (the CD103 − Sirpα + DCmonocyte group) (Fig. 5b) . Notably, however, many of those shared genes were less well conserved in expression by the other members of cluster 2 (spleen and MLN CD4 + DCs). Those genes shared by hDP DCs and cluster 2, which included EMILIN2, ALOX5, THBS1, C3AR1, PRDM1, CLEC10A and VWA5A and genes encoding Fc receptors, may be induced in DCs of clusters 2 and 3 in response to the gut inflammatory environment. Thus, our results defined core lineage-specific gene signatures conserved in mice and humans but also revealed conserved responses to local tissue environments.
Conserved signatures of intestinal CD103 + DC subsets
We next more closely considered the conserved transcriptional profiles of the intestinal CD103 + DC subsets. Among ~700 genes that varied in expression at least twofold between hSP DCs and hDP DCs or between mSP and mDP DCs, only 84 showed coordinated up-or downregulation in both species: 18 genes had higher expression by CD103 + mSP or hSP DCs than by mDP (CD103 + CD11b + mouse) DCs or hDP (CD103 + Sirpα + human) DCs in both species, and 66 genes had higher expression in the hDP and mDP DC subsets ( Fig. 5c  and Supplementary Table 3 ). Although 70 of the 84 genes showed a difference in expression in DCs of cluster 1 versus DCs of cluster 2 in human skin and mouse lymphoid tissues that paralleled the differences in the gut DC subsets, 14 genes did not; these genes either were not expressed differently (a difference in expression of less than twofold) or were discordantly regulated in DCs of cluster 1 versus DCs of cluster 2 in other tissues ( Fig. 5c and Supplementary Table 3) .
Notably, all but one of those 14 genes had higher expression in intestinal mDP or hDP DCs than in CD103 + mSP or hSP DC. That observation suggested that DCs of cluster 2 may have been more responsive to local (tissue-specific) environmental 'imprinting' than were DCs of cluster 1. Those 14 genes (Supplementary Table 3) included genes encoding the chemokine receptor CCR1, the activation-associated migration regulator CD69, the inhibitory receptor PILRA and the cytokine receptor IL-13RA1, as well as the transcription factor Blimp-1 (discussed below). Together these results showed that conserved transcriptional programs that distinguished intestinal CD103 + DC subsets included both core signature genes that distinguished DCs in cluster 1 from DCs in cluster 2 in general, as well as genes whose differences in expression were unique to the gut DC subsets and probably reflected conserved responses to the intestinal environment.
Different expression of Bcl6 and Prdm1 in DC subsets
We hypothesized that transcription factors encoded by genes with different expression in intestinal hDP or mDP DCs versus hSP or mSP DCs might contribute to conserved gut DC specialization. Only seven transcription factors showed conserved differences in gene expression: Irf8 and Bcl6 had higher expression in hSP or mSP DCs than in hDP or mDP DCs, while Irf4, Prdm1, Zeb2, Hivep2 and Foxn3 had npg r e s o u r c e higher expression in hDP or mDP DCs than in hSP or mSP DCs, respectively (Fig. 6a) . Expression of the genes encoding Id2 and BATF3, also linked to the development of intestinal DCs, was higher in hSP or mSP DCs than in hDP or mDP DCs but did not meet the criteria of a twofold difference in expression in both species (data not shown). The roles of ZEB2 or Foxn3 in the development of hematolymphoid cells remain unclear, while Bcl-6 and Blimp-1 (encoded by Prdm1) are transcriptional repressors with counter-regulatory roles in determining the fate of effector B cells and T cells 35, 36 . Bcl6 is downregulated by Blimp-1 in both lymphocyte lineages 37 . Bcl6 expression was highest in LP hSP or mSP DCs, and Bcl6 had higher expression by cross-presenting (SP or CD8α + ) DCs than by CD11b + DCs in all tissues investigated (Fig. 6b) . Prdm1 had overall low expression in splenic CD11b + DCs and high expression in intestinal hDP or mDP DCs (Fig. 6b) .
In line with gene-expression data, flow cytometry showed that Bcl-6 protein expression was higher in hSP DCs than in hDP DCs (Fig. 6c) . We also analyzed Bcl-6 expression through the use of reporter mice that expresses a fusion of yellow fluorescent protein (YFP) and Bcl-6 (YFP-Bcl-6). Among cells from the SI LP, mSP DCs expressed YFP-Bcl-6, whereas mDP DCs showed no YFP-Bcl-6 expression ( Fig. 6d,e) . However, MLN-resident mDP DCs as well as mSP DCs were both YFP-Bcl-6 + (Fig. 6d,e) . Moreover, all DCs from the spleen and peripheral lymph nodes (pLNs) expressed YFP-Bcl-6 ( Fig. 6f) , although it was lower expression than that of mSP DCs from the SI LP or from the MLNs. CD8α + DCs had higher expression of YFP-Bcl-6 than did CD8α − (CD11b + ) DCs, but this difference was more prominent in DCs from the spleen than in DCs from the pLNs (Fig. 6f) . Thus, high Bcl-6 expression marked developmentally and functionally related mSP DCs and CD8α + DCs.
Through the use of reporter mice transgenically expressing YFP under control of the Prdm1 promoter (Blimp-1-YFP mice), we detected high expression of Blimp-1-YFP in mDP DCs from the intestinal LP, while mSP DCs were Blimp-1-YFP − (Fig. 6d,e) . The difference in expression was less pronounced in DCs from the MLNs: in these lymph nodes, mDP DCs had higher expression of Blimp-1-YFP than that of mSP DCs, but mSP DCs expressed the reporter as well (Fig. 6d,e ). CD11b + CD103 − DC from the MLNs (which represent a DC population unrelated to CD11b + CD103 − macrophages from the LP 38 ) did not express Blimp-1-YFP (Fig. 6d,e ). We did not detect Blimp-1-YFP expression in steady-state spleen or pLNs (Fig. 6f) , consistent with the low constitutive Prdm1 expression in spleen DCs (according to data from the Immunological Genome Project). This suggested that Bcl-6 could contribute to DC specification in all organs tested, whereas Blimp-1 might have a selective role in the specification of the intestinal mDP DC subset in the steady state.
Opposing roles of Blimp-1 and Bcl-6 in DC subset specification To investigate the role of Bcl-6 in determining DC fate, we assessed DC subsets in Bcl-6-deficient mice and their heterozygous and wild-type littermates. Phenotypically healthy Bcl-6-deficient mice and wild-type mice had similar frequencies of plasmacytoid DCs versus total cDCs among CD11c + MHCII + DCs from the MLNs (Fig. 7a) and other lymphoid tissues (data not shown), but Bcl-6deficient mice displayed a specific loss of antigen-cross-presenting DC subsets, including mSP DCs from the MLNs, SI LP and colon ( Fig. 7b) and CD8α + DCs from the spleen and pLNs (Fig. 7c) .
To determine whether Bcl-6 acts in a cell-intrinsic way to control DC development, we reconstituted CD45.1 + CD45.2 + wild-type hosts with a mixture of CD45.2 + Bcl-6-deficient and CD45.1 + wild-type bone marrow (Supplementary Fig. 6 ). In these chimeric mice, mSP cDCs were derived almost exclusively from wild-type bone marrow, whereas Bcl-6-deficient and wild-type progenitor cells contributed equally to mDP DCs (Fig. 7d,f) . Similarly, CD8α + cDCs from the pLNs and spleen were derived mainly or exclusively from wildtype donor cells (Fig. 7e) , whereas both Bcl-6-deficient donor cells and wild-type donor cells contributed to CD8α − DCs in lymphoid organs. Together these results suggested a critical and cell-intrinsic role for Bcl-6 in the specification or survival of major classes of crosspresenting DCs.
To assess the role of Blimp-1 in intestinal DCs, we generated mice with DC-specific Blimp-1 deficiency by crossing mice that express Cre recombinase driven by Cd11c with mice with a loxP-flanked stop cassette before Prdm1 (Prdm1 fl/fl ) 39 . Mice with DC-specific Blimp-1 deficiency had a higher percentage of mSP DCs in the MLNs, with a correspondingly lower frequency of mDP DCs (Fig. 8a) . The relative loss of mDP DCs was more pronounced in the intestinal LP, while the frequency of mSP DCs among total CD11c + cells in the LP was similar in mice with DC-specific Blimp-1 deficiency and their Prdm1 fl/fl littermates (Fig. 8a) . The ratio of mDP DCs to mSP DCs in the SI LP and MLNs was reproducibly lower in mice with DC-specific Blimp-1 deficiency than in Prdm1 fl/fl mice (Fig. 8c) . Consistent with the pattern of Blimp-1 expression, DC-specific Blimp-1 deficiency had no significant effect on the relative representation of DC subsets in spleen and pLNs ( Figs. 6 and 8b) . Similarly, Blimp-1 deficiency had no effect on DC subsets in the colonic LP, where mDP DCs are a minor population (data not shown). Thus, Blimp-1 and Bcl-6 reciprocally and in a cell-intrinsic way control mSP and mDP DCs in the SI.
DISCUSSION
Our study has defined three major cDC subsets in the human SI, related them to mouse DC subsets to elucidate evolutionarily conserved and divergent phenotypic and functional properties, and identified roles for the transcriptional regulators Bcl-6 and Blimp-1 in the development and specialization of DCs. CD103 + Sirpα − (hSP) DCs aligned with the human and mouse cross-presenting DC lineage and shared 'preferential' expression of the gene encoding Bcl-6, which we found contributed to the differentiation of this lineage. CD103 + Sirpα + (hDP) DCs were related to the human CD1c + DC lineage and displayed similarities in function, phenotype and transcriptome with npg r e s o u r c e mouse CD103 + CD11b + (mDP) DCs, including expression of Blimp-1, which we found controlled intestinal mDP specification. Finally, we identified CD103 − Sirpα + DCs as a distinct subset related to blood monocytes and with characteristics similar to those of mouse monocyte-derived CD103 − CX3CR1 int inflammatory DCs. Analyses of both transcriptome and phenotype confirmed the close relationship of intestinal hSP DCs with antigen-cross-presenting DC lineages, including CD141 + DCs in humans and lymphoid tissue CD8α + cDCs and intestinal CD103 + CD11b − (mSP) cDCs in mice. hSP DCs expressed CADM1, XCR1 and CLEC9A, molecules with important roles in the cross-priming of CD8 + T cells: CLEC9A is involved in the sensing and endocytosis of dead cells 40 , XCR1 mediates crosstalk with XCL1-secreting CD8 + T cells 41 , and CADM1 engages with the receptor CRTAM on CD8 + T cells 42 and promotes IL-22 production 43 . hSP DCs also 'preferentially' (compared with hDP DCs) expressed transcripts of BATF3 and IRF8, which encode transcription factors that drive development of the CD8α + DC lineage in the mouse.
Comparative transcriptional analyses suggested a relationship between gut hDP DCs and CD1c + DCs from human blood and skin. These DC populations also shared expression of lineage-associated surface antigens, including CD1c itself. However, in contrast to the strong correlation of gene expression in hSP DCs and their blood CD141 + DC counterparts, the transcriptional alignment of hDP DCs and CD1c + DCs was robust only when we eliminated tissuespecific genes from analysis. These observations, as well as our analyses of conserved patterns of gene expression in the lineages, suggested that DCs of the CD1c + cell lineage may be more sensitive than are cross-presenting CD141 + DCs and hSP DCs to local environmental programming 44 .
hDP DCs also aligned phenotypically and functionally with mouse intestinal mDP DCs and more distantly with mouse lymphoid tissue CD4 + DCs. Intestinal hDP DCs and mDP DCs similarly induced T H 17 cells and T reg cells, and both expressed CLEC4A, CD101 and TLR5. These conserved molecules regulate cytokine production and autoimmunity 26, 45 and may mediate evolutionarily critical roles in intestinal immune homeostasis. Our comparative genomics analysis also revealed conserved expression by hDP or mDP DCs of the transcriptional regulators IRF4 (which has been linked to the development of CD4 + DCs and mDP DCs 9 ) and Blimp-1 (shown here to selectively control the specification of intestinal mDP DCs).
Our findings also identified CD103 − Sirpα + intestinal DCs. In two patients with hyperemic jejunal mucosa, there was a greater abundance of this CD103 − Sirpα + DC population, consistent with their recruitment or population expansion during inflammation. The similarities in the transcriptomes of CD103 − Sirpα + DCs and human and mouse blood monocytes lead us to propose that they may develop from monocytes recruited in response to gut inflammation, similar to mouse CX3CR1 int cDCs 34 . CD103 − Sirpα + DCs and mouse CX3CR1 int cDCs both induced efficient proliferation of CD4 + T cells and promoted the production of interferon-γ by T cells. Given the diversity in CX3CR1 + populations in mice, we cannot exclude the possibility of heterogeneity in the CD103 − Sirpa + CX3CR1 int population, nor indeed in the other populations studied here. Further investigation of CD103 − Sirpα + DCs during colitis and other intestinal inflammatory conditions is warranted. The developmental relationship of CD103 − Sirpα + DCs with CD14 − CD11c − anergic macrophages 46 also needs further investigation.
Notably, our analysis of DCs from gut-associated lymphoid tissues suggested that both hSP subsets and hDP subsets were able to access the draining MLNs. hDP DCs also displayed the largest amount of CCR7 and expressed genes associated with enhanced cell motility. Thus, as proposed for mDP DCs, they may be a principal migratory subset that can transport gut antigenic and environmental signals to lymph nodes. hSP DCs also expressed CCR7, but they displayed less CCR7 than did hDP DCs; this may suggest a difference in relative efficiency of exit, but chemokine receptors can be rapidly modulated. The substantial if low expression of CCR7 by Sirpα + CD103 − DCs suggested that they may also be able to migrate to draining lymph nodes.
We found highest expression of Bcl6 in the cross-presenting DC subsets, including hSP and mSP DCs in the gut, and lymphoid tissue CD8α + DCs. Moreover, our results demonstrated an important role for Bcl-6 in the development of those cross-presenting DC populations. Published studies have suggested an overall reduction in mature cDCs in the absence of Bcl-6 (ref. 47 ), a finding we were unable to confirm in healthy Bcl-6-deficient mice. In contrast to Bcl6, Prdm1 had its highest expression in mDP DCs from the small intestine, and that expression correlated with the selective effect of Blimp-1 deficiency on the development of DCs in the SI found in our study. Unexpectedly, Prdm1 expression was significantly higher in mDP DCs from the LP than in mDP DCs from the MLNs, even though mDP DCs in the MLNs are thought to represent recent migrants from the LP 48 . This raises the possibility that Prdm1 expression is actively and potentially reversibly regulated by the local environment in the SI and contributes to the predominant effect of Blimp-1 on mDP DCs in the SI. Prdm1 expression was even lower (and expression of the Blimp-1 reporter was undetectable) among CD8α − CD11b + DCs from the spleen and CD103 − CD11b + DCs from the MLNs, which correlated with a lack of significant effect of Blimp-1 deficiency on those populations in our study. These results suggested a selective role for Blimp-1 in the specification and fate of mDP DCs in the SI. Indeed, even mDP DCs from the colon had low expression of Blimp-1-YFP and were apparently unaffected by Blimp-1 deficiency. Blimp-1 has also been linked to DC-intrinsic tolerance maintenance 39 , and it may therefore contribute to intestinal immunological homeostasis by modulating mDP or hDP DC responses as well as their numbers. Although not reported here, subsets of skin DCs and CD11b + CD103 − mononuclear phagocytes in the SI LP also had high expression of Prdm1 (data not shown); thus, a role for Blimp-1 in such cells should be investigated. Our results suggested key roles for Bcl-6 and Blimp-1 in an evolutionarily conserved transcription factor network that has evolved to control terminal fate 'decisions' in each of the major lineages involved in the adaptive immune response. In conclusion, we have characterized the DC network in the human SI and have defined developmental, phenotypic and functional parallels between the human DC system and the mouse DC system. Our findings provide a framework for translational investigation of the function of gut DC subsets in intestinal immunity and in inflammatory conditions such as food allergies, inflammatory bowel disease and gastritis.
METHODS
Methods and any associated references are available in the online version of the paper.
Immunological Genome Project and the Merad laboratory (Mount Sinai School of Medicine) for generating the publicly available microarray data of sorted mouse intestinal DC. Supported by the US National Institutes of Health (R01 Genome Project Consortium (GEO accession code GSE15907) 38 were used. Gene lists were created in GeneSpring as follows: genes were filtered by expression value (at least one replicate in either subset had to show a raw value above 120), followed by statistical analysis for the exclusion of samples with excessive variability (P > 0.05, between both DC subsets (uncorrected unpaired, twotailed t-test)). We then filtered on probes with a difference in expression of at least twofold in the mSP DCs versus mDP DC subsets. We applied the same filtering criteria to our human data sets to identify genes with a difference in expression of at least twofold in hDP DCs versus hSP DCs. The mouse gene list was then 'translated' into the human experiment in GeneSpring. The intersection of both lists was used for the scatter plot of ratios, generated with the Partek Genomic Suite. For the identification of transcription factors, we used GO Term 0003700 (sequence-specific DNA-binding transcription factor activity).
Mice. Bcl-6-deficient mice (provided by A.D.) were maintained and bred in specific pathogen-free conditions in the animal facility of Veterans Affairs Palo Alto Health Care Systems. YFP-Bcl-6 mice 51 were provided by T. Okada, and Blimp-1-YFP mice 52 were provided by E. Meffre. Both strains were bred and maintained at UCSF. Mice with DC-specific BLimp-1 deficiency and control mice were bred in the animal facility of The Feinstein Institution for Medical Research under specific pathogen-free conditions, and repeat experiments used mice bred at the Veterans Affairs Palo Alto Health Care Systems. All animal work was approved by the Institutional Animal Care and Use Committee of the Veterans Affairs Palo Alto Health Care Systems or by relevant animal care committees at the collaborating institutions.
Isolation of mouse lymphocytes. Spleens, peripheral (inguinal, axillary and brachial) lymph nodes and MLNs were isolated and then were digested for 30 min at 37 °C with RPMI medium containing 5% FCS, 0.5 mg/ml of collagenase IV (Sigma Aldrich) and 1 unit/ml of DNaseI (Sigma) and made into single-cell suspensions. For the isolation of LP-residing DCs from the SI and colon, full-length SI (with Peyer's patches removed) and colon were cut open longitudinally and rinsed twice in Hank's balanced-salt solution (without Ca 2+ or Mg 2+ ) plus 2% FCS and were cut into small pieces. After treatment for a total of 40 min with 1 mM EDTA to release the epithelium, tissues were digested three times for 15 min at 37 °C in 10 ml RPMI medium containing 5% FCS and 0.5 µg/ml of collagenase IV (C2139; Sigma). Supernatant containing LP cells was collected. Mononucleated cells from both colon and SI LP supernatant were isolated by gradient separation at 2,500 r.p.m. for 15 min at room temperature with 40% and 70% Percoll solutions (17-0891-01; GE). Cells of interest were located at the interface.
Flow cytometry of mouse cells and analysis. Nonspecific binding in cells was first blocked with FACS buffer (0.5% BSA in PBS) containing 1 µg/ml anti-CD16/CD32 (93; eBioscience). The following antibodies were used for staining: phycoerythrin-indotricarbocyanine-Alexa Fluor 780-anti-CD3 (145-2C11; Biolegend), phycoerythrin-indotricarbocyanine-Alexa Fluor 780-anti-CD19 (ID3; BD), phycoerythrin-indotricarbocyanine-Alexa Fluor 780-anti-NK1.1 (PK136; eBioscience), phycoerythrin-indotricarbocyanine-Alexa Fluor 700-Alexa Fluor 780-anti-B220 (RA3-6B2; eBioscience), Alexa Fluor 700-Alexa Fluor 780-anti-MHC class II (M5/114.15.2; eBioscience), Pacific blue-phycoerythrin-indotricarbocyanine-anti-CD11c (N418; eBioscience), phycoerythrin-fluorescein isothiocyanate-allophycocyaninanti-CD103 (M290; eBioscience), peridinin chlorophyll protein-cynanine 5.5-anti-CD11b-(M1/70; eBioscience), BDHorizon V500-anti-CD8 (53-6.7, BD), allophycocyanin-Alexa Fluor 780-anti-CD45.1 (A20; eBioscience), fluorescein isothiocyanate-anti CD45.2 (104; eBioscience), phycoerythrinallophycocyanin-anti-CLEC4A (33D1; Biolegend), phycoerythrinanti-CD101 (Moushi101, ; Biolegend) and allophycocyanin-anti-TLR3 (11F8; Biolegend). Dead cells were excluded by staining with propidium iodide (Sigma). Flow cytometry data were acquired on an LSRII or a Fortessa (BD) with FACSDiva software (BD). FlowJo (Treestar) was used for further analysis. Statistical comparisons of all flow cytometry-based data were calculated with unpaired Student's t-test (GraphPad Prism software).
Generation of mixed-bone marrow chimeras. Donor bone marrow cells
were collected from femurs and tibias, and bone marrow was flushed out with a 27-guage needle. After lysis of red blood cells, cells were counted, and 5 × 10 6 cells in total were injected into lethally irradiated recipient mice (1,000 reads). To ensure equal engraftment by different donor cells, the following groups were set up: Bcl-6-deficient mouse-derived bone marrow cells on a CD45.2 + allogeneic background with wild-type mouse-derived donor cells on a CD45.1 + background served as the experimental group, and wild-type mouse-derived donor cells on both backgrounds served as a control group. For the latter, we used littermates of Bcl-6-deficient mice as CD45.2 + wildtype mice to ensure for proper engraftment by this strain. At least six different mixed bone marrow groups were set up, with successful engraftment from both donor cell populations in all groups tested.
Statistical analysis. The statistical significance of differences between the two sets of data was assessed by Student's t-test unless stated otherwise. Analytic methods for significance of differential gene expression are indicated in the text. Significance of clusters was determined by modified bootstrap resampling 53 .
